Sharps Technology Inc. (STSS) is experiencing a surge in demand for its high-quality smart safety syringe products, which has led to an increase in interest from potential customers. The medical device and pharmaceutical packaging company recently received two purchase orders for approximately 1 million SecureGard ultra-low waste smart safety syringes produced at Sharps’ manufacturing facility in Hungary.
The first shipment of 100k syringes is scheduled for the third week of July, with additional deliveries planned throughout the rest of 2024. The undisclosed customer is a Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies, marking the beginning of a potential collaboration that could utilize Sharps’ technology, product portfolio, and development expertise to support the customer’s expanding product line.
Sharps Technology specializes in the development and manufacturing of drug delivery systems, with a focus on low-waste and ultra-low-waste syringe technologies that incorporate active safety features and re-use prevention measures accredited by the World Health Organization. These features help protect healthcare workers from needle stick injuries and prevent the dangers of needle re-use. With manufacturing facilities in Hungary and plans to expand in South Carolina, Sharps is working to increase its manufacturing capacity in the U.S.
The demand for innovative injection solutions is rapidly increasing due to market growth and concerns surrounding tariffs, recalls, and quality issues with Chinese-supplied syringes. As such, Sharps has seen a surge in interest and potential demand for its high-quality smart safety syringe products. The company’s commitment to innovation in drug delivery systems and focus on safety measures position it well for continued growth and success in the pharmaceutical packaging industry.